ERNST & YOUNG ADDS RID/FDA PRACTICE WITH DOME SYSTEMS PURCHASE
Executive Summary
ERNST & YOUNG ADDS RID/FDA PRACTICE WITH DOME SYSTEMS PURCHASE: June 20 acquisition of the Indianapolis-based firm brings focus on systems development, regulatory services and technical communications for pharmaceutical and life sciences companies. Dome, founded in 1981, now has 42 consultants working on "the development of strategic information systems for healthcare firms." Ernst & Young says the firm had revenues of $3.7 mil. last year.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth